| (Values in U.S. Thousands) | Jun, 2026 | Mar, 2026 | Mar, 2025 | Mar, 2025 | Dec, 2024 |
| Sales | 6,310 | 7,220 | 8,820 | 0 | 0 |
| Sales Growth | -12.60% | -18.14% | unch | unch | unch |
| Net Income | -67,260 | -61,450 | -41,690 | 0 | 0 |
| Net Income Growth | -9.45% | -47.40% | unch | unch | unch |
Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Generate Biomedicines Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. Generate Biomedicines Inc. is based in SOMERVILLE, Mass.
Fiscal Year End Date: 12/31